Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER
No-Receipt date
2018-03618 - 11/10/2018
No-Filing date
20180402873 - 11/10/2018
No-Granting date
3097578 - 26/11/2018
No-EPO application date
10011772.0 - 24/11/2006
No-EPO granting date
2325210 - 05/09/2018
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
11/2018 - 25/02/2019
Expiration date
25/11/2026
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
EP0502565724/11/2005/EP
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 39/00
A61K 39/395
A61K 45/06
A61K 51/10
A61P 35/00
C07K 16/18
C07K 16/28
C07K 16/30
C12N 5/12
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
943547
ASTELLAS PHARMA INC.
5-1, NIHONBASHI-HONCHO 2-CHOME
CHUO-KU TOKYO 103-8411
JAPAN
943548
TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG- UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH
FREILIGRATHSTRASSE 12
55131 MAINZ
GERMANY
Inventors
Code
Firstname
Surname
2357263
SAHIN, UGUR
2357264
TURECI, OZLEM
2357265
USENER, DIRK
2357266
FRITZ, STEFAN
2357267
UHEREK, CHRISTOPH
2357268
BRANDENBURG, GUNDA
2357269
GEPPERT, HARALD-GERHARD
2357270
SCHRODER, ANJA KRISTINA
2357271
THIEL, PHILIPPE
Representatives
Code
Firstname
Surname
Address
Town
Zip
3098
ANNA
GIAKOUMI
ALKAMENOUS 12-14
ATHINA (ATTIKIS)
10439
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8397
ANDRONIKI
MISIOU
ANALIPSEOS 23 KAI MARATHONOS 27
VRILISSIA (ATTIKIS)
15235
GREECE
Owners History
Title Instruments
Payments history
19 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).